Former Boston Scientific Executive Joins Ceryx Medical’s Board

Ceryx Medical has appointed Mark Strong, a former executive from Boston Scientific and Abbott, as a non-executive board director. This strategic move aims to strengthen Ceryx Medical’s position in the cardiac rhythm management (CRM) market by leveraging Strong’s extensive experience in product development, commercialization, and regulatory navigation. His expertise is expected to guide the company’s growth, enhance product offerings, and expand market reach in the evolving CRM sector.